Tricuspid valve disease and cardiac implantable electronic devices.

Andreas, Martin; Burri, Haran; Praz, Fabien; Soliman, Osama; Badano, Luigi; Barreiro, Manuel; Cavalcante, João L; de Potter, Tom; Doenst, Torsten; Friedrichs, Kai; Hausleiter, Jörg; Karam, Nicole; Kodali, Susheel; Latib, Azeem; Marijon, Eloi; Mittal, Suneet; Nickenig, Georg; Rinaldi, Aldo; Rudzinski, Piotr; Russo, Marco; ... (2024). Tricuspid valve disease and cardiac implantable electronic devices. European Heart Journal, 45(5), pp. 346-365. Oxford University Press 10.1093/eurheartj/ehad783

Text ehad783.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (1MB) | Request a copy

The role of cardiac implantable electronic device (CIED)-related tricuspid regurgitation (TR) is increasingly recognized as an independent clinical entity. Hence, interventional TR treatment options continuously evolve, surgical risk assessment and peri-operative care improve the management of CIED-related TR, and the role of lead extraction is of high interest. Furthermore, novel surgical and interventional tricuspid valve treatment options are increasingly applied to patients suffering from TR associated with or related to CIEDs. This multidisciplinary review article developed with electrophysiologists, interventional cardiologists, imaging specialists, and cardiac surgeons aims to give an overview of the mechanisms of disease, diagnostics, and proposes treatment algorithms of patients suffering from TR associated with CIED lead(s) or leadless pacemakers.

Interest & Impact

Downloads

0 since deposited on 15 Dec 2023
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item